Keep Up With the Latest Headlines in Dermatology from the Past Week

First-of-Its-Kind Study Links Psoriasis and OCD

A recent study has revealed a possible connection between psoriasis and obsessive-compulsive disorder (OCD) in US adults. According to researchers at Yale School of Medicine, using data from the All of Us Research Program, individuals with psoriasis had a 1.5-fold increase in odds for an OCD diagnosis. While the correlation does not prove causation, researchers suggest that symptoms associated with psoriasis, such as chronic itching, could predispose individuals to OCD. They also suspect that both conditions share inflammatory pathways. It is the first study of its kind in American adults and could help shed light on potential new ways to treat these conditions.

DermTech Files for Bankruptcy to Restructure Debt and Sell Assets

DermTech, a San Diego-based company that provides noninvasive skin cancer detection stickers, has filed for bankruptcy protection in order to restructure its debt and sell its assets. Despite the company’s efforts to stabilize its finances over the past year through leadership changes and layoffs, it was unable to overcome challenges posed by the tough financing environment. The bankruptcy filing aims to ensure continued laboratory operations while pursuing asset sales.

European Court of Justice Rules Against “Skin Friendly” Advertising of Disinfectants

The European Court of Justice recently ruled that products like disinfectants cannot be advertised as “skin friendly.” The decision came after a German federal court sought clarification on a case against a drugstore chain that labeled its hand, skin, and surface disinfectant as “skin friendly.” The ruling is based on European Union regulations on biocidal products, which prohibit promoting them with terms like “low-risk,” “nontoxic,” “harmless,” “natural,” “environmentally friendly,” or “animal friendly,” or any similar indication. The EU court concluded that the term “skin friendly” implies positive connotations that could mislead consumers into believing that the product is beneficial for the skin, thus justifying its prohibition in advertising.

Conclusion

Despite the challenges faced by DermTech, the company remains committed to providing innovative solutions to detect skin cancer noninvasively. The study linking psoriasis and OCD offers promising insights into potential new treatments, while the European Court of Justice’s decision on disinfectant labeling highlights the importance of accurate and transparent marketing. Stay tuned for more developments on these topics and other dermatology news.

Originally Post From https://www.dermatologytimes.com/view/derm-in-the-news-june-16-22

Read more about this topic at
The Dermatology Digest: Home
Headlines in Dermatology Archives